NEU 0.32% $15.65 neuren pharmaceuticals limited

Share Price, page-10192

  1. 489 Posts.
    lightbulb Created with Sketch. 282
    Hi Richo

    During the webinar of 29 Feb 24, Jon mentioned that the bar for the PH and Angelman p-values should be the Phase 3 Rett trial results (2021) and NOT the recent PMS results (as these results were so good, it may set the bar too high). I’ll post a screenshot of the 2021 p-values separately as HC never lets me post text and pics together.

    Good luck everyone for the upcoming trial results - especially the patient populations.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.